HomeOwner SearchCategory Search
Visit USCOJournal of Ocular Pharmacology and Therapeutics [Published: 2015-01-16 to 2015-03-05. Issues: vol. 31, no. 1, January/February 2015 to vol. 31, no. 2, March 2015]
Serial Registration
Copyright Title
Journal of Ocular Pharmacology and Therapeutics [Published: 2015-01-16 to 2015-03-05. Issues: vol. 31, no. 1, January/February 2015 to vol. 31, no. 2, March 2015]
Status
Published
on 28 May 2015
Year of Creation
2015
Copyright Claimant
Mary Ann Liebert, Inc
Registration Number
TX0008165617
on 28 May 2015Copyright Summary
The U.S. Copyright record (Registration Number: TX0008165617) dated 28 May 2015, pertains to an electronic file (eService) titled "Journal of Ocular Pharmacology and Therapeutics [Published: 2015-01-16 to 2015-03-05. Issues: vol. 31, no. 1, January/February 2015 to vol. 31, no. 2, March 2015]" created in 2015. The copyright holder is Mary Ann Liebert, Inc, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to Mary Ann Liebert, Inc.
Application Details
Registration Number
TX0008165617
Registration Date
5/28/2015
Year of Creation
2015
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Mary Ann Liebert, Inc
First Publication Nation
United States
ISSN
1080-7683
Notes
Copyright Local Holdings: vol. 31, no. 1, January/February 2015 Pub. 2015-01-16 Reg. 2015-05-14 TX0008165617 STEKvol. 31, no. 2, March 2015 Pub. 2015-03-05 Reg. 2015-05-14 TX0008165617 STEK
Statements
Application Title Statement: Journal of Ocular Pharmacology and Therapeutics
Author Statement: Mary Ann Liebert, Inc employer for hire Authorship: Collective Work
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.